The association between funding by commercial interests and study outcome in randomized controlled drug trials.
Explore this paper's citation graph
Summary
An association was found between the source of study support and the published outcome of randomized controlled drug trials in general interest medical journals.
- Type
- article
- Published
- 2001-12-01
- Cited by
- 159
- References
- 13
- Access
- Open access
- OpenAlex
- https://openalex.org/W2099086046
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24542081
Keywords
Medicine, Association (psychology), Randomized controlled trial, Drug, Drug trial
References
- Publication bias: evidence of delayed publication in a cohort study of clinical research projects
- An amnesty for unpublished trials
- Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
- A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.
- The Quality of Drug Studies Published in Symposium Proceedings
- Conflict of interest in the debate over calcium-channel antagonists.
- Publication bias in clinical research.
- Conflict of interest in the debate over calcium-channel antagonists.
- Treatment of arthritis.
- Conflict of interest.
- A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis
- Being a modern pharmaceutical company
- Is there a bias in industry supported clinical research
Cited by
- The continuing story of dhat syndrome
- Clinical trial registration promotes patient protection and benefit, advances the trust of everyone, and is required.
- Evolution of the randomized controlled trial in oncology over three decades.
- If the Facts Were Not Untruths, Their Implications Were: Sponsorship Bias and Misleading Communication
- Apples and zebras.
- Clinical Trials and the Independence of Investigators
- Depression and antidepressants in Australia and beyond: A critical public health analysis
- Are claims of advertisements in medical journals supported by RCTs?
- Clinical trial information: developing an effective model of dissemination and a framework to improve transparency
- Should Academic Emergency Departments Collaborate in Pharmaceutical Industry-Sponsored Research?
- Declaracions de conflictes d’interès i política editorial a les revistes biomèdiques espanyoles publicades en castellà
- Reforming FDA Policy for Pediatric Testing: Challenges and Changes in the Wake of Studies Using Antidepressant Drugs
- The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
- Owning the Genome
- McCarthyism, conflict of interest and addiction's new transparency declaration procedures.
- Brains, claims, and the pharmaceutical industry
- Publication bias in the medical literature: A review by a Canadian research ethics board
- Risperidone alone or in combination for acute mania.
- Industry sponsorship and research outcome.
- Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology.
Related papers
- [Clinical trials in Norway--completion and reporting are not satisfactory].
- Investigator clinical trials: How can we ask the question?
- Do current clinical trials meet society's needs?: a critical review of recent evidence.
- Regulatory of drug clinical trials in China
- Global issues in drug development for Alzheimer's disease
- Alzheimer's disease drug development pipeline: 2021